Polymorphism and Pharmacological Assessment of Carbamazepine
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189835 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alberto Sá Filho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil. Hauptthemen laut MEDLINE: Carbamazepine, Anticonvulsants. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Goiás—FAPEG, Conselho Nacional de Desenvolvimento Científico e Tecnoló gico—CNPq.
Abstract (Originalsprache)
This work provides insight into carbamazepine polymorphs (Forms I, II, III, IV, and V), with reports on the cytoprotective, exploratory, motor, CNS-depressant, and anticonvulsant properties of carbamazepine (CBZ), carbamazepine formulation (CBZ-F), topiramate (TOP), oxcarbazepine (OXC), and diazepam (DZP) in mice. Structural analysis highlighted the significant difference in molecular conformations, which directly influence the physicochemical properties; and density functional theory description provided indications about CBZ reactivity and stability. In addition to neuron viability assessment in vitro, animals were treated orally with vehicle 10 mL/kg, as well as CBZ, CBZ-F, TOP, OXC, and DZP at the dose of 5 mg/kg and exposed to open-field, rotarod, barbiturate sleep induction and pentylenetetrazol (PTZ 70 mg/kg)-induced seizure. The involvement of GABAergic mechanisms in the activity of these drugs was evaluated with the intraperitoneal pretreatment of flumazenil (2 mg/kg). The CBZ, CBZ-F, and TOP mildly preserved neuronal viability. The CBZ-F and the reference AEDs potentiated barbiturate sleep, altered motor activities, and attenuated PTZ-induced convulsion. However, flumazenil pretreatment blocked these effects. Additional preclinical assessments could further establish the promising utility of CBZ-F in clinical settings while expanding the scope of AED formulations and designs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil.
- Institute of Biological Sciences, Federal University of Goiás, Goiás 74605-010, GO, Brazil.
- Structural and Theoretical Chemistry Group, State University of Goiás, Anápolis 75083-515, GO, Brazil.
ORCID-Profile: Alberto Sá Filho, Gustavo Rodrigues Pedrino, Osmar Nascimento Silva, Hamilton Barbosa Napolitano, James Oluwagbamigbe Fajemiroye
Förderung
- Fundação de Amparo à Pesquisa do Estado de Goiás—FAPEG
- Conselho Nacional de Desenvolvimento Científico e Tecnoló gico—CNPq
Zitieren
APA
Sá Filho, A., Martins, J. L. R., Costa, R. F., Pedrino, G. R., Duarte, V. S., Silva, O. N., Napolitano, H. B., & Fajemiroye, J. O. (2024). Polymorphism and Pharmacological Assessment of Carbamazepine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189835
Vancouver
Sá Filho A, Martins JLR, Costa RF, Pedrino GR, Duarte VS, Silva ON, et al. Polymorphism and Pharmacological Assessment of Carbamazepine. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189835
BibTeX
@article{SFilho2024,
author = {Sá Filho, Alberto and Martins, Jose Luis Rodrigues and Costa, Rafael Fernandes and Pedrino, Gustavo Rodrigues and Duarte, Vitor Santos and Silva, Osmar Nascimento and Napolitano, Hamilton Barbosa and Fajemiroye, James Oluwagbamigbe},
title = {Polymorphism and Pharmacological Assessment of Carbamazepine},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189835}
}
EUVIMED